Publications by authors named "A M Traish"
Article Synopsis
- * The TRAVERSE study, published in June 2023, found no increased risk of major cardiovascular events in men receiving testosterone therapy compared to a placebo, countering earlier studies that suggested potential risks.
- * Based on the TRAVERSE findings and extensive previous research, the Androgen Society concludes that testosterone therapy is not linked to higher risks of heart attacks, strokes, or cardiovascular deaths.
Purpose: Dry-eye disease (DED) is a chronic progressive ocular surface disorder with limited studies in the pediatric population. The Academy of Ophthalmology's IRIS® Registry was leveraged to investigate the prevalence of DED in the pediatric population (PDED, patients <18 years old) and the demographic differences of DED between pediatric and adult patients (ADED).
Methods: Retrospective cohort study.
Introduction: Low testosterone (T) levels are associated with obesity, metabolic syndrome, type 2 diabetes mellitus and altered lipid profiles, thus contributing to increased cardiovascular disease risk. Hence T deficiency has a detrimental effect on men's vascular health, quality of life and increased mortality.
Objectives: This review aims to present summary of data in the contemporary clinical literature pertaining to the benefits of T therapy in clinical studies with varying durations on vascular health in men with T deficiency.
Purpose: To report a pediatric patient with bilateral temporal keratoconus.
Observations: A 14-year-old male presented with a two-year history of progressively worsening visual acuity in both eyes and suspicion for undiagnosed amblyopia in the right eye. Retinoscopy revealed a scissoring reflex in both eyes and corneal topography demonstrated high keratometry values (Kmax 57.